Imaging Core
成像核心
基本信息
- 批准号:7944551
- 负责人:
- 金额:$ 18.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-19 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdvisory CommitteesAlgorithmsAntineoplastic AgentsAreaArizonaArtsBiological MarkersBioluminescenceCancer CenterCancer Center Support GrantClinicalClinical TrialsCommitCommunitiesComputer softwareConfocal MicroscopyConsultationsCore FacilityCustomData AnalysesDetectionDevelopmentEconomicsEndoscopyEquipmentFiber OpticsGene ExpressionGoalsHousingImageImage AnalysisImaging DeviceImaging technologyInternetIonsMagnetic Resonance ImagingMaintenanceMalignant NeoplasmsMicroscopeMissionModalityMusOperative Surgical ProceduresOpticsPatientsPharmaceutical PreparationsProtocols documentationResearchResearch PersonnelSeriesServicesSpectrum AnalysisSuggestionTechnical ExpertiseTechniquesTechnologyTrainingcostimage processingimprovedin vivoinstrumentluminescencemembermolecular imagingoncologyoptical imagingpre-clinicalprogramsresponsesingle photon emission computed tomographysoftware developmentstatisticsweb site
项目摘要
9.1.7 IMAGING CORE SHARED SERVICE
The Cancer Center and affiliated programs house equipment and expertise in the development and application of
a variety of in vivo imaging modilities including PET/SPECT, MR and optical approaches to in vivo imaging. The
mission of the Imaging Core service is to provide Cancer Center members easy access to these state-of-the art in
vivo imaging capabilities. Within this context, the Imaging Core provides three specific services to the Cancer
Center members. An Institutional Imaging Advisory Committee provides a mechanism through which
investigators may initiate projects, have them critically reviewed and facilitate access to appropriate image
acquisition modalities. Optical imaging capabilities in confocal imaging, bioluminescence analysis of gene
expression, and confocal endoscopy and spectroscopy are provided. The Core also provides access to technical
expertise for operating and analyzing data acquired for pre-clinical MRI, PET/SPECT, and OCT, as well as.
Clinical MRI approaches. A second area of focus, the Core is responsible for developing standardized platforms
for image analysis housed in a centralized facility where experts in image processing and development of custom
analysis algorithms are consolidated. The image processing facility, housed in the MRB, provides access to high
end graphics computing capabilities, and experts who can provide both basic training and advice in image
analysis approaches, as well as expertise to develop and customize specific image processing techniques.
Thirdly, the Imaging Response Assessment Team (IRAT) has been incorporated into the ICSS for this renewal.
The goal of this program is to increase the use of functional and molecular imaging endpoints as biomarkers in
clinical drug trials. As such, all protocols initiated by AZCC investigators are vetted by the IRAT committee, who
provide documented suggestions for inclusion of imaging endpoints. Consequently, the IRAT at AZCC will strictly
conform to the ideals and concepts of the IRAT program and is committed to participating in the national
consortium of IRATs focused on the use of quantitative imaging in clinical trials.
9.1.7成像核心共享服务
癌症中心和附属计划的房屋设备以及在开发和应用方面的专业知识
各种体内成像模式,包括PET/SPECT,MR和体内成像的光学方法。这
成像核心服务的任务是为癌症中心成员轻松访问这些最新技术
体内成像功能。在这种情况下,成像核为癌症提供了三个特定服务
中心成员。机构成像咨询委员会提供了一种机制
调查人员可以启动项目,对他们进行严格审查并促进访问适当的图像
采集方式。共聚焦成像中的光学成像能力,基因生物发光分析
提供了表达,共聚焦内窥镜和光谱法。核心还提供技术访问
用于运营和分析用于临床前MRI,PET/SPECT和OCT的数据的专业知识以及。
临床MRI接近。第二个重点领域,核心负责开发标准化平台
用于图像分析,位于集中式设施中
分析算法是合并的。位于MRB中的图像处理设施可提供高高的访问权限
结束图形计算功能,以及可以在图像中提供基础培训和建议的专家
分析方法以及开发和自定义特定图像处理技术的专业知识。
第三,成像响应评估团队(IRAT)已纳入了ICS的续订。
该程序的目的是增加功能和分子成像终点作为生物标志物的使用
临床药物试验。因此,AZCC调查人员发起的所有协议均由IRAT委员会审查,后者
提供有关包含成像端点的文献建议。因此,AZCC的IRAT将严格严格
符合IRAT计划的理想和概念,并致力于参加国家
IRAT的联盟重点是在临床试验中使用定量成像。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD LYNCH其他文献
RONALD LYNCH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD LYNCH', 18)}}的其他基金
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Using natural killer cells to prevent breast cancer metastases
使用自然杀伤细胞预防乳腺癌转移
- 批准号:
10591362 - 财政年份:2023
- 资助金额:
$ 18.87万 - 项目类别:
Elucidating anti-angiogenic tyrosine kinase inhibitor-induced vascular dysfunction
阐明抗血管生成酪氨酸激酶抑制剂诱导的血管功能障碍
- 批准号:
10570393 - 财政年份:2023
- 资助金额:
$ 18.87万 - 项目类别:
Engineering Immuno-Glial-Neurovascular 3D-Brain-Chips with a Perfusable BBB for Accelerating Alzheimer’s Disease Drug Discovery and Translation
工程免疫胶质神经血管 3D 脑芯片与可灌注 BBB 加速阿尔茨海默病药物发现和转化
- 批准号:
10741377 - 财政年份:2023
- 资助金额:
$ 18.87万 - 项目类别:
Dissecting enhancer-promoter looping and gene induction dynamics in differentiation
剖析分化过程中的增强子-启动子循环和基因诱导动态
- 批准号:
10642028 - 财政年份:2023
- 资助金额:
$ 18.87万 - 项目类别:
Tachycardia-induced Metabolic Remodeling Drives Cardiac Dysfunction
心动过速引起的代谢重塑导致心脏功能障碍
- 批准号:
10738875 - 财政年份:2023
- 资助金额:
$ 18.87万 - 项目类别: